Key result
Point-of-care ultrasound rapidly identified depressed left ventricular systolic function in an adolescent presenting with chest pain following Pfizer-BioNTech COVID-19 vaccination.
Why the study?
A growing number of adolescents are being diagnosed with acute myocarditis following mRNA COVID-19 vaccinations, requiring rapid diagnosis and risk stratification methods.
Case Report (n=1)
Point-of-care ultrasound may serve as a rapid tool to diagnose or risk stratify patients with potential post-COVID-19 vaccine myocarditis.
A growing number of adolescents are being diagnosed with acute myocarditis following mRNA COVID-19 vaccinations. This case describes an adolescent who presented to the emergency department with chest pain and tachycardia following the Pfizer-BioNTech COVID-19 vaccination. Point-of-care ultrasound was performed prior to the return of laboratory studies and revealed depressed left ventricular systolic function. Point-of-care ultrasound may be a tool used to rapidly diagnose or risk stratify patients with potential post-COVID-19 vaccine myocarditis.
No takes yet. Share an insight, caveat, or question.
A 2021 study conducted a case report in Post-COVID-19 vaccine myocarditis (n=1). Point-of-care ultrasound was evaluated on Depressed left ventricular systolic function. Point-of-care ultrasound rapidly identified depressed left ventricular systolic function in an adolescent presenting with chest pain following Pfizer-BioNTech COVID-19 vaccination.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: